GAINESVILLE, Fla.–(BUSINESS WIRE)–#ConceptCompanies—Concept Companies, a Gainesville headquartered full-service real estate development and construction firm, has announced commencement of construction on a new office and lab building in Copeland Park for Lacerta Therapeutics, a clinical-stage gene therapy company. The 12,950 square foot building is expected to be completed in the Spring of 2020. Strategically located in … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Biomedical Temperature Sensors – Global Market Outlook (2017-2026)” report has been added to ResearchAndMarkets.com’s offering. The Global Biomedical Temperature Sensors market accounted for $5.6 billion in 2017 and is expected to reach $10.1 billion by 2026 growing at a CAGR of 6.8% during the forecast period. Some of the key factors influencing the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Diabetes Management: Insulin Pumps Market (2019)” report has been added to ResearchAndMarkets.com’s offering. The Global Insulin Pumps market is being driven by strong demand, increasing awareness and adoption of next-generation hybrid closed-loop systems, solid clinical outcomes, and good reimbursement. Market penetration is low, leaving much room for growth. According to the International Diabetes … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–#biotech—Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the appointment of seasoned biotech executive, George Ng, Partner of PENG Life Science Ventures. His extensive background includes co-founding and leading the efforts of a pharmaceutical company from pre-clinical to clinical to New Drug … [Read more…]

LONDON–(BUSINESS WIRE)–#ArcherDanielsMidlandCompany–Technavio has been monitoring the global superfoods market since 2016 and the market is poised to grow by USD 201.67 billion during 2019-2023, progressing at a CAGR of 17% during the forecast period. Request Free Sample Pages Read the 114-page research report with TOC on “Superfoods Market Analysis Report by Product (superfruits, superseeds and … [Read more…]

New facility will be a major research and development hub for molecular spectroscopy SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies, Inc. (NYSE: A) today announced the opening of a new state-of-the-art facility for spectroscopy research and development at the Harwell Science and Innovation Campus in Oxfordshire, UK. A leader in molecular spectroscopy, the new Agilent site will … [Read more…]

ESPOO, Finland–(BUSINESS WIRE)–#AMR–Mobidiag Ltd., a revenue generating, molecular diagnostics company with complementary platforms that address antimicrobial resistance and other areas of unmet diagnostic need, today announces the CE-IVD marking of the Novodiag® Stool Parasites test, a comprehensive and cost-effective molecular diagnostic test for the detection of intestinal parasites directly from stool samples. Tuomas Tenkanen, CEO … [Read more…]

Data will communicate new and updated findings, including in the treatment of psoriasis, atopic dermatitis and chronic hand eczema BALLERUP, Denmark–(BUSINESS WIRE)–LEO Pharma A/S, a global leader in medical dermatology, today announced that data from company-sponsored, health economic outcome and investigator-initiated studies will be presented at the 28th annual Congress of the European Academy of … [Read more…]

Real-world data from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) shows that BENEPALI™ is effective in patients with psoriasis   INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. today announced real-world data of BENEPALI™ in patients with moderate to severe psoriasis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). The results … [Read more…]

First study to find direct evidence that therapeutic gene is transferred from the injected eye to the uninjected contralateral eye of primates Findings support mechanism for bilateral visual improvement with unilateral GS010 gene therapy, which was consistently observed in LHON subjects in the REVERSE and RESCUE Phase III trials PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: … [Read more…]